From pregnancy to protection: advancing the intersection between antenatal care and immunization

Posted on

By: Cyril Engmann, member of AMI’s Strategic Leadership Team and Program Lead for Maternal, Newborn, Child Health, and Nutrition at PATH; Jessica Fleming, Director of AMI and Maternal Immunization Delivery Lead for PATH

A maternal RSV vaccine, which is quickly advancing through clinical trials and could be available as early as 2021, is a natural opportunity for MNCH and immunization programs to come together like never more